NVS Short Volume
Novartis AG (NVS) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $270.68B, listed on NYSE, employing roughly 75,267 people, carrying a beta of 0.42 to the broader market. Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Led by Vasant Narasimhan, public since 1996-11-07.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-10-14
- Short Volume
- 232.8K
- Total Volume
- 546.2K
- Short %
- 42.61%
- 30-Day Avg Short %
- 34.18%
Showing 30 days of FINRA short volume data for Novartis AG.
Learn how short volume is reported and how to read the data →
Frequently asked NVS short volume questions
- What is the daily NVS short volume?
- As of Oct 14, 2026, Novartis AG (NVS) short volume is 232.8K shares against 546.2K total reported volume, or 42.61% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is NVS short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does NVS short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.